🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
4,720 results for “eu”
MedicineActive substanceLicence holderStatus
Lenalidomide Krka 15 mg hard capsules
EU/1/20/1519/009-010
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 2.5 mg hard capsules
EU/1/20/1519/001-002
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 20 mg hard capsules
EU/1/20/1519/011-012
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 25 mg hard capsules
EU/1/20/1519/013-014
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 5 mg hard capsules
EU/1/20/1519/003-004
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 7.5 mg hard capsules
EU/1/20/1519/005-006
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Mylan 10 mg hard capsules
EU/1/20/1490/009-010
Lenalidomide Mylan Pharmaceuticals Limited
Lenalidomide Mylan 15 mg hard capsules
EU/1/20/1490/011-012
Lenalidomide Mylan Pharmaceuticals Limited
Lenalidomide Mylan 2.5 mg hard capsules
EU/1/20/1490/001-003
Lenalidomide Mylan Pharmaceuticals Limited
Lenalidomide Mylan 20 mg hard capsules
EU/120/1490/013-015
Lenalidomide Mylan IRE Healthcare Limited
Lenalidomide Mylan 25 mg hard capsules
EU/1/20/1490/016-018
Lenalidomide Mylan Pharmaceuticals Limited
Lenalidomide Mylan 5 mg hard capsules
EU/1/20/1490/004-005
Lenalidomide Mylan Pharmaceuticals Limited
Lenalidomide Mylan 7.5 mg hard capsules
EU/1/20/1490/006-008
Lenalidomide Mylan Pharmaceuticals Limited
LENVIMA 10 mg hard capsules
EU/1/15/1002/002
Lenvatinib mesylate Eisai GmbH
LENVIMA 4 mg hard capsules
EU/1/15/1002/001
Lenvatinib mesylate Eisai GmbH
LEQEMBI 100 mg/mL concentrate for solution for infusion
EU/1/24/1891/001-002
Lecanemab Eisai GmbH
Leqvio 284 mg solution for injection in pre-filled syringe
EU/1/20/1494/001
Inclisiran Novartis Europharm Limited
Lescol XL 80 mg Prolonged-release tablets
PA23517/001/001
Fluvastatin sodium Ethyx Pharmaceuticals Marketed
Letrozole Bluefish 2.5 mg film-coated tablets
PA1436/013/001
Letrozole Bluefish Pharmaceuticals AB Marketed
Letybo 50 units powder for solution for injection
PA0846/001/001
Clostridium Botulinum Neurotoxin Type A (900 KD) Croma-Pharma GmbH Marketed
Leucovorin-Teva 10mg/ml Concentrate for Solution for Infusion
PA0749/001/001
Folinic acid Teva Pharma B.V. Marketed
Leukeran 2 mg film-coated tablets
PA1691/007/001
Chlorambucil Aspen Pharma Trading Limited Marketed
Leuprex 3, 5mg Implant
PA0711/188/001
Leuprorelin acetate Rowex Limited, Marketed
LEVEMIR (INSULIN DETEMIR)
EU/1/04/278/1-9
Insulin detemir Novo Nordisk A/S
Levemir 100 units/ml Solution for injection in pre-filled pen
EU/1/04/278/010-011
Insulin determir Novo Nordisk A/S
Levetiracetam Accord 1000 mg film-coated tablets
EU/1/11/712/022-028
Levetiracetam Accord Healthcare S.L.U.
Levetiracetam Accord 250 mg film-coated tablets
EU/1/11/712/001-007
Levetiracetam Accord Healthcare S.L.U.
Levetiracetam Accord 500 mg film-coated tablets
EU/1/11/712/008-013
Levetiracetam Accord Healthcare S.L.U.
Levetiracetam Accord 750 mg film-coated tablets
EU/1/11/712/015-021
Levetiracetam Accord Healthcare S.L.U.
Levetiracetam Actavis 1000 mg film-coated tablets
EU/1/11/713/031-040
Levetiracetam Actavis Group hf
Levetiracetam Actavis 250 mg film-coated tablets
EU/1/11/713/001-010
Levetiracetam Actavis Group hf
Levetiracetam Actavis 500 mg film-coated tablets
EU/1/11/713/011-020
Levetiracetam Actavis Group hf
Levetiracetam Actavis 750 mg film-coated tablets
EU/1/11/713/021-030
Levetiracetam Actavis Group hf
Levetiracetam Actavis Group 100 mg/ml oral solution
EU/1/11/738/001-003
Levetiracetam Actavis Group hf
Levetiracetam Hospira 100 mg/ml concentrate for solution for infusion
EU/1/13/889/001-002
Levetiracetam Pfizer Europe MA EEIG
Levetiracetam Kabi 10 mg/ml solution for infusion
PA2059/088/002
Levetiracetam Fresenius Kabi Deutschland GmbH Not marketed
Levetiracetam Kabi 5 mg/ml solution for infusion
PA2059/088/001
Levetiracetam Fresenius Kabi Deutschland GmbH Not marketed
Levetiracetam ratiopharm 100 mg/ml oral solution
EU/1/11/702/001-003
Levetiracetam Ratiopharm GmbH
Levetiracetam ratiopharm 1000 mg film-coated tablets
EU/1/11/702/025-031
Levetiracetam Ratiopharm GmbH
Levetiracetam ratiopharm 250 mg film-coated tablets
EU/1/11/702/004-009
Levetiracetam Ratiopharm GmbH
Levetiracetam ratiopharm 500 mg film-coated tablets
EU/1/11/702/010-017
Levetiracetam Ratiopharm GmbH
Levetiracetam ratiopharm 750 mg film-coated tablets
EU/1/11/702/018-024
Levetiracetam Ratiopharm GmbH
Levetiracetam SUN 100 mg/ml concentrate for solution for infusion
EU/1/11/741/001
Levetiracetam Sun Phamaceutical Industries Europe B.V.
Levetiracetam Teva 1000 mg film-coated tablets
EU/1/11/701/022-028
Levetiracetam Teva Pharma B.V.
Levetiracetam Teva 250 mg film-coated tablets
EU/1/11/701/001-004
Levetiracetam Teva Pharma B.V.
Levetiracetam Teva 500 mg film-coated tablets
EU/1/11/701/008-014
Levetiracetam Teva Pharma B.V.
Levetiracetam Teva 750 mg film-coated tablets
EU/1/11/701/015-021
Levetiracetam Teva Pharma B.V.
LEVITRA
EU/1/03/248/1-12
Vardenafil Bayer AG
Levitra 10 mg orodispersible tablets
EU/1/03/248/013-15
VARDENAFIL HYDROCHLORIDE TRIHYDRATE Bayer Schering Pharma AG
Levobupivacaine 0.625 mg/ml solution for infusion
PA2059/009/001
Levobupivacaine Fresenius Kabi Deutschland GmbH Marketed
40 41 42 43 44 45 46
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.